KIZ OpenIR  > 科研部门  > 肿瘤生物学(陈策实)
Roles of RNF126 and BCA2 E3 ubiquitin ligases in DNA damage repair signaling and targeted cancer therapy
Zhang, Rou; Liu, Wenjin; Sun, Jian; Kong, Yanjie; Chen, Ceshi
2020
发表期刊PHARMACOLOGICAL RESEARCH
ISSN1043-6618
卷号155
摘要The dysfunction of E3 ubiquitin ligases is important in the pathogenesis of many human diseases, as they play important roles in multiple cellular processes. In this review, we evaluated the structures, functions and clinical significance of two RING-type E3 ubiquitin ligases from the same subfamily, ring-finger protein 126 (RNF126) and breast cancer associated gene 2 (BCA2). Interestingly, the expression of RNF126 and BCA2 are regulated by multiple signaling pathways, including EGFR, ERK, AKT, and NF-kappa B. RNF126 and BCA2 appear to be functional mediators for not only DNA damage repair but also cancer development. Due to their significant functions in cell proliferation and DNA damage repair, RNF126 and BCA2 may be two potential diagnostic biomarkers and therapeutic targets for cancers.
收录类别sci
语种英语
文献类型期刊论文
条目标识符http://ir.kiz.ac.cn/handle/152453/12876
专题科研部门_肿瘤生物学(陈策实)
推荐引用方式
GB/T 7714
Zhang, Rou,Liu, Wenjin,Sun, Jian,et al. Roles of RNF126 and BCA2 E3 ubiquitin ligases in DNA damage repair signaling and targeted cancer therapy[J]. PHARMACOLOGICAL RESEARCH,2020,155.
APA Zhang, Rou,Liu, Wenjin,Sun, Jian,Kong, Yanjie,&Chen, Ceshi.(2020).Roles of RNF126 and BCA2 E3 ubiquitin ligases in DNA damage repair signaling and targeted cancer therapy.PHARMACOLOGICAL RESEARCH,155.
MLA Zhang, Rou,et al."Roles of RNF126 and BCA2 E3 ubiquitin ligases in DNA damage repair signaling and targeted cancer therapy".PHARMACOLOGICAL RESEARCH 155(2020).
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
2021110103.pdf(2897KB)期刊论文出版稿开放获取CC BY-NC-SA请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhang, Rou]的文章
[Liu, Wenjin]的文章
[Sun, Jian]的文章
百度学术
百度学术中相似的文章
[Zhang, Rou]的文章
[Liu, Wenjin]的文章
[Sun, Jian]的文章
必应学术
必应学术中相似的文章
[Zhang, Rou]的文章
[Liu, Wenjin]的文章
[Sun, Jian]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。